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Since the ﬁrst report of robotic gastrectomy, experienced laparoscopic surgeons have used surgical robots to treat gastric cancer and
resolve problems associated with laparoscopic gastrectomy. However, compared with laparoscopic gastrectomy, the superiority of
robotic procedures has not been clearly proven. There are several advantages to using robotic surgery for gastric cancer, such as
reduced estimated blood loss during the operation, a shorter learning curve, and a larger number of examined lymph nodes
than conventional laparoscopic gastrectomy. The increased operation time observed with a robotic system is decreasing because
surgeons have accumulated experience using this procedure. While there is limited evidence, long-term oncologic outcomes
appear to be similar between robotic and laparoscopic gastrectomy. Robotic procedures have a signiﬁcantly greater ﬁnancial cost
than laparoscopic gastrectomy, which is a major drawback. Recent clinical studies tried to demonstrate that the beneﬁts of
robotic surgery outweighed the cost, but the overall results were disappointing. Ongoing studies are investigating the beneﬁts of
robotic gastrectomy in more complicated and challenging cases. Well-designed randomized control trials with large sample sizes
are needed to investigate the beneﬁts of robotic gastrectomy compared with laparoscopic surgery.
1. Introduction
Minimal invasive surgery is considered to be the alternative
standard for treating early gastric cancer. Previous studies
have demonstrated beneﬁts of minimal invasive surgery
compared with open surgery with respect to postoperative
pain, hospital stay, gastrointestinal function recovery, and
return to normal activity [1–5]. In addition to postoperative
outcomes, recent multicenter prospective randomized clin-
ical trials showed that treating early gastric cancer with
laparoscopic gastrectomy was suﬃciently safe in terms of
oncological aspects and could be established as the stan-
dard procedure in clinical practice [6]. However, some
problems have not been solved, such as D2 lymph node
dissection, anastomosis technique, and oncological safety
in advanced gastric cancer. To overcome these challenges,
surgeons investigated new techniques and instruments for
the treatment of gastric cancer.
The da Vinci® Surgical System (Intuitive Surgical Inc.,
Sunnyvale, CA, USA) was developed in 1988. This robotic
system was designed to address problems related to laparo-
scopic surgery. Since the robotic gastrectomy procedure
was introduced [7], experienced laparoscopic surgeons have
used this surgical system to treat gastric cancer. Recent
reports demonstrated that robotic gastrectomy was a safe
and feasible alternative treatment for gastric cancer com-
pared with conventional laparoscopic gastrectomy [8–10].
However, to date, there are no well-designed prospective ran-
domized trials investigating robotic gastric cancer surgery. In
this review, we describe the current state of the ﬁeld and its
prospects for the treatment of gastric cancer.
2. Overview and History
By 2015, 3597 da Vinci Surgical Systems had been installed
worldwide and used in approximately 650,000 procedures,
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usually for urological, gynecological, and general surgical
procedures. The ﬁrst robotic gastrectomy was reported in
2003 [7], and surgeons in the ﬁeld of minimally invasive
surgery adopted this new surgical approach as an experimen-
tal procedure for the treatment of gastric cancer. Robotic
surgical systems oﬀer several advantages, including high-
resolution 3-D images, an EndoWrist® with seven degrees
of freedom, and tremor ﬁltering. Thus, this technique was
expected to increase the accuracy and thoroughness of mini-
mally invasive gastrectomy [11, 12].
Our institution also hoped that the unique advantages of
robotic surgery could help with overcoming the limitations of
laparoscopic surgery in gastric cancer treatment. In 2005, we
adopted the robotic surgical system for the treatment of gas-
tric cancer and have performed the largest numbers thereof
in this ﬁeld. Initial applications were limited only to early
gastric cancer; however, this has been expanded alongside
the expansion of indications for minimally invasive surgery.
Regardless of the issues related to this new technology,
including its tremendous ﬁnancial cost, subjective percep-
tions of proﬁciency during the procedure among surgeons
and some noted beneﬁts in postoperative outcomes seem to
have encouraged our surgeons to continue with performing
robotic gastrectomy.
In the literature, several investigational case series
(Table 1) and retrospective studies (Table 2) investigated
robotic gastrectomy compared with conventional gastrec-
tomy for the treatment of gastric cancer. Recently, Wang
et al. reported a single-center randomized clinical trial for
robotic gastrectomy compared with open gastrectomy [13].
This report showed that robotic gastrectomy group had less
blood loss (94.2± 51.5 versus 152.8± 76.9ml, p < 001), a
shorter hospital stay (5.6± 1.9 versus 6.7± 1.9 days,
p = 021), and earlier recovery of bowel function (2.6± 1.1
versus 3.1± 1.2 days, p = 028), but a longer operation time
(242.7± 43.8 versus 192.4± 31.5min, p = 002), than the
open gastrectomy group. The complication rate and number
of retrieved lymph nodes were not diﬀerent between the two
groups. Most comparative studies compared short-term
surgical outcomes between robotic and laparoscopic gastrec-
tomy. However, to our knowledge, there are no well-designed
randomized trials investigating robotic gastrectomy com-
pared with conventional laparoscopic gastrectomy. One large
nonrandomized multicenter prospective study comparing
robotic and laparoscopic gastrectomy in Korea was recently
reported. The results showed that perioperative surgical out-
comes of robotic gastrectomy were not superior to those of
laparoscopic gastrectomy [14].
3. Issues regarding Robotic Gastrectomy
3.1. Operation Time. Previous comparative studies observed
a longer operation time for robotic gastrectomy compared
with that for conventional laparoscopic gastrectomy,
although the statistical signiﬁcance of the diﬀerence varied
between studies. One of the major factors prolonging
operation time in robotic surgery was docking and addi-
tional preoperation time [15, 16]. In addition, the initial
learning curve of a procedure can also prolong operation
time [17]. Eom et al. suggested that a robotic operating
system, in which the surgeon alone performs the roles of
operator, assistant, and camera operator, could contribute
to the lengthy operation time for robotic gastrectomy
[18]. However, a recent report on robotic gastrectomy
showed that the operation time of the later 100 cases
was signiﬁcantly shorter than that of the earlier 100 cases
[19]. Huang et al. also observed that operation time and
docking time reduced signiﬁcantly after completing a
learning curve of 25 procedures [20]. A comparative study
of robotic and laparoscopic gastrectomies performed by
one experienced surgeon showed that the total operation
time using robotic system was not statistically longer than
that of laparoscopy [21]. Clearly, operation time decreases
as the surgeon gains experience with the robotic system.
3.2. Blood Loss. Previous studies reported that robotic gas-
trectomy produced less estimated blood loss than conven-
tional gastrectomy [10, 12, 22–26]. In addition, recent
meta-analyses comparing robotic and laparoscopic gastrec-
tomy showed that there was a trend toward reduced blood
loss when a robotic system was used [27, 28]. Reduced
blood loss can be attributed to the three-dimensional view
and EndoWrist function found in robotic systems. Notably,
these results were achieved early in the learning curve [29].
However, the level of evidence included in these systematic
reviews was not high enough to draw strong conclusions
due to a lack of randomized trials. For example, one study
reported increased blood loss early in their experience with
a robotic system [18]. A recent multicenter nonrandomized
prospective comparative study of robotic versus laparo-
scopic gastrectomy for gastric cancer showed that estimated
blood loss was similar between the two groups [14]. A sub-
group analysis of that study showed that the robotic group
had signiﬁcantly lower estimated blood loss than the lapa-
roscopic group during D2 lymph node dissection [30].
Lee et al. reported that in terms of blood loss, the beneﬁts
of a robotic approach were more apparent for high BMI
patients when performing a distal gastrectomy with D2
lymph node dissection [25]. The reduction of blood loss
probably has little impact on immediate patient outcomes.
However, it may have oncological beneﬁts because it could
minimize the dissemination of free cancer cells during gas-
trectomy for cases of advanced gastric cancer, which is not
a trivial concern [31–33].
3.3. Length of Hospital Stay. Compared with open gastrec-
tomy, robotic gastrectomy had a shorter length of postoper-
ative hospital stay [10, 13]. However, most studies showed
no diﬀerence in length of hospital stay when comparing
robotic and laparoscopic gastrectomies. This result could
be due to the similar number of trocars used and slightly
longer operation times required for robotic gastrectomy
[11, 18, 22–26, 34–36]. Meanwhile, several reports showed
shorter hospital stays for patients undergoing robotic gastrec-
tomy compared with those undergoing laparoscopic surgery
[6, 37–39]. Suda et al. reported that postoperative hospital stay
was14days in the robotic gastrectomygroupand15days in the
laparoscopic gastrectomy group (p = 021) [40]. Similarly,
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Kim et al. reported shorter hospital stays for robotic sur-
gery (6.7± 1.0 versus 7.4± 2.4 days in the laparoscopic sur-
gery group, p < 001) [6]. In this report, the shorter
hospital stay could be due to the relatively younger age
of the robotic gastrectomy group (54.1± 12.0 versus 60.5
± 11.0 years in the laparoscopic surgery group, p < 001).
An age-controlled comparative study showed no statistical
diﬀerence in hospital stay between patients of various ages
undergoing robotic or laparoscopic gastrectomy (robotic
gastrectomy in elderly patients; age 74.8± 4.8; hospital
stay, 5 days versus robotic gastrectomy in young patients;
age 51.1± 10.2; hospital stay, 5 days versus laparoscopic
gastrectomy in elderly patients; age 73.1± 3.7; hospital
stay, 6 days) [36]. Based on the postoperative stay results,
it is unclear whether robotic gastrectomy has an advantage
with respect to postoperative recovery.
3.4. Cost. The use of a robotic system to treat certain diseases
remains controversial, primarily due to cost-eﬀectiveness.
The higher cost is the main disadvantage for patients under-
going robotic gastrectomy. In a report from Korea, the total
cost diﬀerence between robotic and laparoscopic surgery
was US$4490 or more [14]. The proportion of the cost paid
by patients was even higher. Currently, the beneﬁts of robotic
over laparoscopic gastrectomy do not justify the higher cost
of the robotic procedure [34]. In addition, the higher cost
of the robotic gastrectomy procedure hinders the execution
of randomized trials. However, the issue of cost, which is
inﬂated due to instrument depreciation and maintenance,
could be reduced if competing surgical robotic systems were
made available [14].
3.5. Learning Curve. The learning curve of robotic gastrec-
tomy is known to be shorter compared with that of laparo-
scopic surgery. However, most studies reporting on the
learning curve of robotic gastrectomies enlisted experienced
laparoscopic surgeons [20, 41]. Typically, 40–60 cases are
needed to overcome the learning curve of laparoscopic gas-
trectomy [42–45], whereas a recent report showed that 12–
14 cases were suﬃcient to overcome the learning curve of
robotic surgery [46]. The shorter learning curve of robotic
gastrectomy could allow even inexperienced surgeons to
adopt the robotic technique easily and rapidly [47].
3.6. Lymph Node Dissection. D2 lymph node dissection is
the recommended treatment for advanced gastric cancer
[48–50]. Due to the technical diﬃculty and higher mor-
bidity associated with D2 lymph node dissection, laparo-
scopic gastrectomy is typically restricted to cases of early
gastric cancer. Dissecting around the suprapancreatic area
is one of the most diﬃcult parts in a laparoscopic gastrec-
tomy. Comparative analyses between robotic and open
gastrectomies reported no signiﬁcant diﬀerence in the total
number of retrieved lymph nodes [13]. Recent compara-
tive studies between robotic and laparoscopic gastrecto-
mies also showed no diﬀerence in the total number of
retrieved lymph node [14, 25]. However, when evaluating
the number of retrieved lymph nodes in the N2 area,
robotic gastrectomy yielded more lymph nodes from this
technically challenging area [6]. A thorough dissection in
the N2 area is critical in cases of gastric cancer to improve
oncological results [51]. Additionally, a comparative study
of spleen-preserving total gastrectomies revealed that the
mean numbers of retrieved lymph nodes in lymph node sta-
tions 10 and 11 were higher for robotic gastrectomy than lap-
aroscopic gastrectomy (3.6 versus 1.9 retrieved N2 area
lymph nodes; p = 014) even though the total number of
retrieved lymph nodes was similar between the two groups
(47.2 versus 42.8 total retrieved lymph nodes; p = 210)
[11]. The high-resolution 3-D images, articulated instru-
ments with seven degrees of freedom, and tremor elimination
oﬀered in robotic systems could allow surgeons to meticu-
lously retrieve lymph nodes around complicated vascular
structures or vital organs. This result is important because a
recent review of laparoscopic gastrectomy for gastric cancer
showed that it could retrieve fewer numbers of lymph nodes
compared with that of open gastrectomy [52].
3.7. Long-Term Outcome. Only a few studies investigated
long-term outcomes of robotic gastrectomy for gastric can-
cer. Coratti et al. showed that 5-year overall survival after
robotic gastrectomy was 100%, 84.6%, 76.9%, and 21.5% in
pathological stages IA, IB, II, and III, respectively. In this
study, 5-year overall survival for patients with stage I and II
disease was acceptable. These patients also had a low inci-
dence of tumor recurrence and cancer-related mortality.
For more advanced stages (III-IV), long-term survival with
robotic gastrectomy was unsurprisingly poor; however, the
survival was comparable to that of open and laparoscopic
gastrectomy [53]. Nakauchi et al. showed that 3-year overall
survival following robotic gastrectomy was 94.7%, 90.9%,
89.5%, and 62.5% in pathological stages IA, IB, II, and III,
respectively. These results were also comparable to those
observed for laparoscopic gastrectomy (96.2%, 95.1%,
83.8%, and 64.8% in stage IA, IB, II, and III, respectively)
[38]. Although these results were produced by retrospective
analyses, they indicate that robotic gastrectomy for gastric
cancer may be safe in terms of oncological outcomes.
4. Application for Technically Demanding
Procedure
Recent studies investigated the beneﬁts of robotic surgery in
speciﬁc patient types, such as those with advanced gastric
cancer, those needing total gastrectomy, those with high
BMI, and those with remnant gastric cancer. For advanced
gastric cancer surgery, robotic gastrectomy retrieved a larger
number of N2 area lymph nodes, as mentioned previously.
The importance of complete suprapancreatic lymph node
dissection in advanced disease had been shown to improve
oncological outcomes [54]. In the subgroup analysis of a
multicenter prospective comparative study, the robotic gas-
trectomy group showed signiﬁcantly lower estimated blood
loss than the laparoscopic gastrectomy group after D2
lymph node dissection (98.9± 105.7 versus 140.5± 143.1;
p = 021), whereas no diﬀerence in estimated blood loss
was observed in patients that underwent less extensive
lymph node dissection (96.5± 144.2 versus 82.6± 91.7;
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p = 365) [30]. In addition, a recent report showed that
robotic gastrectomy is safe in terms of the incidence of post-
operative pancreatic ﬁstulas, compared with laparoscopic
gastrectomy, following suprapancreatic lymph node dissec-
tion (10% versus 22.5%; p < 001) [55]. Suda et al. also dem-
onstrated similar results regarding less postoperative
pancreatic ﬁstula after robotic gastrectomy than laparoscopic
surgery (conventional laparoscopic group, pancreatic ﬁstula
grade I: II: IIIa, 4 : 4 : 19 versus robotic group, grade I: II: IIIa,
8 : 0 : 0) [40]. These results might be brought about by the
aforementioned advantages of robotic systems, such as
three-dimensional magniﬁed view with high deﬁnition,
tremor ﬁltering, and motion scaling [56, 57]. Further well-
designed studies should be conducted to investigate if there
are real beneﬁts to robotic gastrectomy compared with lapa-
roscopy in advanced gastric cancer.
While the use of minimally invasive techniques to per-
form distal subtotal gastrectomies has increased for both
early and advanced gastric cancer, its use for upper gastric
cancer has increased at a slower rate. It is the favored method
in 49% of early gastric cancer cases and 6% of advanced gas-
tric cancer cases due to the intrinsic diﬃculty in performing a
total gastrectomy [58]. Several studies used robotic systems
to perform total gastrectomies in upper gastric cancer
patients and demonstrated acceptable short-term outcomes
[59, 60]. Yoon et al. showed that the robotic total gastrectomy
group had a longer operation time (305.8± 115.8 versus
210.2± 57.7min; p < 001) but similar numbers of retrieved
lymph node (42.8± 12.7 versus 39.4± 13.4; p = 209) and
postoperative complications (16.7% versus 15.4) compared
with the laparoscopic total gastrectomy group [61]. In a com-
parative study of robotic and laparoscopic spleen-preserving
total gastrectomy, no diﬀerence in short-term outcomes was
observed; however, there were slightly larger numbers of
lymph nodes removed from speciﬁc areas, as mentioned
above [11]. Robotic surgery could potentially be favored for
technically demanding procedures [40, 62].
Because obesity is a risk factor for postoperative compli-
cations, conducting minimally invasive surgery in obese
patients with gastric cancer can be challenging [63]. Lee
et al. suggested that robotic surgery was better than laparo-
scopic gastrectomy with respect to the rate of adequately
retrieved lymph nodes (more than 15 retrieved lymph nodes)
in high BMI patients [25]. However, a recent report of a mul-
ticenter prospective study did not observe additional beneﬁts
using robotic procedures for obese patients compared with
laparoscopic surgery [30]. Thus, the impact of robotic sur-
gery in obese patients remains controversial.
One study investigated the use of a robotic system for
remnant gastric cancer. Kwon et al. compared open and
minimally invasive surgical techniques, including robotic
surgery, for remnant gastric cancer. This study showed
that completion total gastrectomy for remnant gastric can-
cer using minimally invasive techniques, including eight
robotic cases, resulted in improved short-term outcomes
and comparable oncological results compared with open
surgery. For surgeons experienced in the techniques, the
robotic approach could be decent option for managing
remnant gastric cancer [64].
5. Future Applications for Robotic Systems in
Gastric Cancer Treatment
Recently, image-guided surgery was introduced in the ﬁeld of
surgical oncology. Using infrared cameras installed on cur-
rent robotic systems, ﬂuorescent images can be incorporated
into the surgical view [65]. Robotic systems can produce
reconstructed vascular images and intraoperative endoscopic
and radiologic images for the surgeon, reducing unwanted
organ or vascular injury during gastrectomy [66]. Reduced
port or single incision surgery for gastric cancer has been
reported for laparoscopic gastrectomy [67, 68]. These proce-
dures showed acceptable and feasible outcomes when per-
formed by experienced gastric surgeons who had suﬃcient
previous experience with conventional laparoscopic gastrec-
tomy [67]. Recently, our institution reported the results of a
phase I/II clinical trial of reduced port robotic gastrectomy,
ﬁnding it to be a safe and feasible operation for early gastric
cancer [69]. We have conﬁdence that the advantages pro-
vided by a robotic surgical system could make these challeng-
ing procedures more comfortable to perform. So far, there is
no solid evidence that robotic surgery can expand the indica-
tions of minimally invasive gastrectomy; however, based on
our experiences and in light of emerging evidence, robotic
surgery holds a greater possibility of being accepted for tech-
nically demanding procedures for treating gastric cancer
than laparoscopic surgery.
6. Conclusion
The superiority of robotic procedures over conventional lap-
aroscopic gastrectomy has not been proven at present.
Despite the technical advantages of robotic surgery, its cost-
eﬀectiveness remains a major drawback. In the future, well-
designed randomized trials with large sample sizes are
needed to provide answers to controversial issues regarding
the use of robotic systems for treating gastric cancer.
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